Abstract
Preclinical researches on mesenchymal stem cells (MSCs) transplantation, which is used to treat hypoxic-ischemic (HI) brain damage, have received insp......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
